Literature DB >> 13618735

Serum enzymes; variations of activity in disease of muscle.

L P WHITE.   

Abstract

In a study of 58 patients with various diseases of muscle or of the neuromuscular system, the serum activity of various enzymes was measured. Abnormal elevation of serum activities of aldolase, lactic dehydrogenase and, to a lesser extent, glutamic-oxalacetic transaminase and phosphohexose isomerase, was an almost constant feature in patients with progressive muscular dystrophy. These elevations were very frequent in dermatomyositis, common in acute cerebral vascular accidents, and rarely seen in other neurological disorders. Abnormal serum activity of iso-citric dehydrogenase was not observed in the course of the present study. Supplementary protein feeding of patients with muscular dystrophy had no effect on serum enzyme activity, no consistent effect on urinary creatine excretion and no effect on the strength of the patient or the course of the disease. Dystrophic muscles from a dystrophic strain of mice showed a decrease in activity of lactic dehydrogenase and aldolase below that of control muscle and an increase of iso-citric dehydrogenase activity. These findings, taken with the differences in serum activities of lactic dehydrogenase, aldolase and isocitric dehydrogenase in the dystrophic animals, support the conclusion that dystrophic animals handle these soluble enzymes in quite different ways.

Entities:  

Keywords:  ENZYMES/in blood; MUSCLES/diseases

Mesh:

Substances:

Year:  1959        PMID: 13618735      PMCID: PMC1577511     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  29 in total

1.  Treatment of muscular dystrophy with amino acids and vitamins.

Authors:  S M WALD; R L LAM
Journal:  Neurology       Date:  1955-12       Impact factor: 9.910

2.  Muscular dystrophy. VIII. Trials of protein hydrolysate, vitamin supplements, and physical therapy.

Authors:  J S DONALDSON; M J WRATNEY; A PASCASSIO; F A WEIGAND; T S DANOWSKI
Journal:  AMA J Dis Child       Date:  1956-05

3.  Failure of muscular dystrophy treatment with a protein hydrolysate.

Authors:  A L DREW; F KRUSE; C J PELLETIER
Journal:  Neurology       Date:  1954-10       Impact factor: 9.910

4.  The clinical significance of serum aldolase.

Authors:  J A SIBLEY; G A FLEISHER
Journal:  Proc Staff Meet Mayo Clin       Date:  1954-11-10

5.  Evaluation of protein hydrolysate therapy in treatment of muscular dystrophy.

Authors:  D K ZIEGLER; T G VON STORCH
Journal:  J Am Med Assoc       Date:  1955-01-29

6.  The origin of urinary creatine in progressive muscular dystrophy.

Authors:  J D BENEDICT; H J KALINSKY; L A SCARRONE; A R WERTBEIM; D STETTEN
Journal:  J Clin Invest       Date:  1955-01       Impact factor: 14.808

7.  Creatine and creatinine metabolism and diseases of the neuromuscular system.

Authors:  A T MILHORAT
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1953

8.  Biochemical study of muscle in progressive muscular dystrophy.

Authors:  J C DREYFUS; G SCHAPIRA; F SCHAPIRA
Journal:  J Clin Invest       Date:  1954-05       Impact factor: 14.808

9.  [Elevation of the serum aldolase level; biochemical test in myopathy].

Authors:  G SCHAPIRA; J C DREYFUS; F SCHAPIRA
Journal:  Sem Hop       Date:  1953-06-10

10.  Progressive muscular dystrophy; a preliminary report on treatment with amino acids, folic acid and vitamins.

Authors:  J R VAN METER
Journal:  Calif Med       Date:  1953-10
View more
  5 in total

1.  [Progressive muscular dystrophy. I. The heterogenicity of serum lactic dehydrgenase].

Authors:  R RICHTERICH; E GAUTIER; W EGLI; K ZUPPINGER; E ROSSI
Journal:  Klin Wochenschr       Date:  1961-04-01

2.  Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase.

Authors:  R J PENNINGTON
Journal:  Biochem J       Date:  1961-09       Impact factor: 3.857

3.  Serum enzymes and genetic carriers in muscular dystrophy.

Authors:  C S CHUNG; N E MORTON; H A PETERS
Journal:  Am J Hum Genet       Date:  1960-03       Impact factor: 11.025

4.  Biochemistry of dystrophic muscle. 2. Some enzyme changes in dystrophic mouse muscle.

Authors:  R J Pennington
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

5.  [Comparative studies of various TPN dependent dehydrogenases and other serum enzymes in patients with progressive muscular dystrophy].

Authors:  G Giusti; A Ascione; L Cacciatore
Journal:  Klin Wochenschr       Date:  1967-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.